Melissa Vetter

799 total citations
8 papers, 597 citations indexed

About

Melissa Vetter is a scholar working on Molecular Biology, Plant Science and Cancer Research. According to data from OpenAlex, Melissa Vetter has authored 8 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Plant Science and 3 papers in Cancer Research. Recurrent topics in Melissa Vetter's work include Chromosomal and Genetic Variations (3 papers), RNA and protein synthesis mechanisms (3 papers) and Breast Cancer Treatment Studies (2 papers). Melissa Vetter is often cited by papers focused on Chromosomal and Genetic Variations (3 papers), RNA and protein synthesis mechanisms (3 papers) and Breast Cancer Treatment Studies (2 papers). Melissa Vetter collaborates with scholars based in Germany, United States and Netherlands. Melissa Vetter's co-authors include Haig H. Kazazian, John L. Goodier, Lili Zhang, Irene Godoy, Eric Ostertag, Hiroki Kano, George L. Gerton, Richard Cordaux, Mark A. Batzer and Laurel A Bastone and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Melissa Vetter

7 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa Vetter Germany 5 518 429 109 36 28 8 597
Lindsay M. Payer United States 10 516 1.0× 374 0.9× 137 1.3× 63 1.8× 44 1.6× 13 646
Mart Speek Estonia 10 753 1.5× 542 1.3× 135 1.2× 49 1.4× 40 1.4× 17 856
Jared P. Steranka United States 12 617 1.2× 485 1.1× 177 1.6× 73 2.0× 67 2.4× 16 770
Brook Pyhtila United States 7 542 1.0× 179 0.4× 90 0.8× 72 2.0× 25 0.9× 8 657
Chad Huff United States 8 334 0.6× 167 0.4× 210 1.9× 54 1.5× 15 0.5× 11 495
John V. Moran United States 5 429 0.8× 371 0.9× 85 0.8× 19 0.5× 32 1.1× 5 478
Kensaku Murano Japan 13 501 1.0× 226 0.5× 50 0.5× 31 0.9× 27 1.0× 20 574
Ramakrishna K. Chodavarapu United States 4 682 1.3× 572 1.3× 155 1.4× 38 1.1× 17 0.6× 4 979
LeeAnn Ramsay Canada 6 796 1.5× 437 1.0× 109 1.0× 284 7.9× 50 1.8× 7 925
Christ Leemans Netherlands 7 623 1.2× 107 0.2× 78 0.7× 24 0.7× 17 0.6× 13 660

Countries citing papers authored by Melissa Vetter

Since Specialization
Citations

This map shows the geographic impact of Melissa Vetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Vetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Vetter more than expected).

Fields of papers citing papers by Melissa Vetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Vetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Vetter. The network helps show where Melissa Vetter may publish in the future.

Co-authorship network of co-authors of Melissa Vetter

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Vetter. A scholar is included among the top collaborators of Melissa Vetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Vetter. Melissa Vetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Vetter, Melissa, et al.. (2023). 280P Adjuvant aromatase inhibitors in patients with PIK3CA mutation early breast cancer. Annals of Oncology. 34. S296–S296.
2.
Vetter, Melissa, Tilmann Lantzsch, J Buchmann, et al.. (2012). Abstract P2-10-38: Prognostic factors uPA/PAI-1: measurement in core needle biopsies. Cancer Research. 72(24_Supplement). P2–10. 3 indexed citations
3.
Kano, Hiroki, Irene Godoy, Melissa Vetter, et al.. (2009). L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes & Development. 23(11). 1303–1312. 285 indexed citations
4.
Thomssen, Christoph, Melissa Vetter, Martina Schmidt, et al.. (2009). ASCO-recommended prognostic factors uPA/PAI-1 in node-negative (N0) breast cancer patients (pts) compared to clinicopathological risk assessment within the NNBC 3-Europe trial. Journal of Clinical Oncology. 27(15_suppl). 544–544. 6 indexed citations
5.
Madjar, H., et al.. (2008). Untersuchungen zur normalen Vaskularisation der weiblichen Brust durch Doppler-Ultraschall. Ultraschall in der Medizin - European Journal of Ultrasound. 13(4). 171–177. 2 indexed citations
6.
Goodier, John L., Lili Zhang, Melissa Vetter, & Haig H. Kazazian. (2007). LINE-1 ORF1 Protein Localizes in Stress Granules with Other RNA-Binding Proteins, Including Components of RNA Interference RNA-Induced Silencing Complex. Molecular and Cellular Biology. 27(18). 6469–6483. 217 indexed citations
7.
Vetter, Melissa, et al.. (2006). Extensive individual variation in L1 retrotransposition capability contributes to human genetic diversity. Proceedings of the National Academy of Sciences. 103(17). 6611–6616. 77 indexed citations
8.
Vetter, Melissa, et al.. (2000). Agent-driven online business in virtual communities. 10 pp. vol.2–10 pp. vol.2. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026